Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
批准号:
8865555
负责人:
Phillip A Sharp
金额:
$144.02万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 2016-05-31
关键词:
AffectBiologyCancer ControlCell DeathCell Death InductionCell Differentiation processCell LineCell NucleusCell SurvivalCell physiologyCellsCollaborationsComplementComplexDNA DamageDevelopmentDevelopmental ProcessDiagnosisE2F1 geneEctopic ExpressionFamilyGene Expression ProfileGene Expression RegulationGenesGeneticGenetic TranscriptionGenomicsGoalsGrowthHigh-Throughput RNA SequencingHumanInstructionInvestigationLocationMalignant NeoplasmsMesenchymalMesenchymal Cell NeoplasmMesenchymal Stem CellsMessenger RNAMethodsMicroRNAsMusMutationNormal CellNull LymphocytesOncogenesPathway interactionsPhenotypePopulationPreventionProcessProteinsRNARNA InterferenceReactionResearchRoleShapesSmall RNATranscriptional RegulationTumor BiologyTumor Stem CellsTumor SuppressionTumor Suppressor GenesTumor Suppressor ProteinsUntranslated RNAcancer cellcancer gene expressioncancer therapyhuman DICER1 proteinimprovedin vivoinsightinterestmigrationmouse modelneoplastic cellnew technologyprogramspromoterprotein expressionsarcomatranscription factortumortumor growth
中文摘要
描述(由申请人提供):该项目的主要优势是将基因调控的变化与小鼠癌症模型相结合,并将这些结果与人类癌症相关联。当前项目的总体目标是研究短链和长链非编码rna在癌症发展中的作用,以及Rb-E2F通路在细胞死亡和恶性肿瘤中的重要性。mirna可能与所有mrna的一半相互作用,抑制大多数mrna的表达水平不到两倍,但在小鼠模型中清楚地调节癌症的发展。这些小rna调节生长和细胞死亡基因,两者都是肿瘤生长的调节剂,它们也影响发育转变。该项目的第一个总体目标是研究miRNA功能缺失对细胞活力、发育过程和恶性肿瘤发展的影响。这三个项目正在研究miRNAs在基因调控中的一般作用,包括它们的作用机制,所有miRNAs在Dicer null细胞系中丢失的后果,以及miRNAs与间充质肿瘤和干细胞分化之间的关系。靶向小鼠遗传学将用于研究miRI43-145簇在发育和肿瘤抑制中的作用。这将涉及探索激活该mirna家族的影响
英文摘要
DESCRIPTION (provided by applicant): A major strength of the Program is the integration of changes in gene regulation with mouse models of cancer and relating these results to human cancer. The overall goals of the current Program is to investigate the roles of both short and long non-coding RNAs in the development of cancer and the importance of the Rb-E2F pathway in cell death and malignancy. miRNAs probably interact with half of all mRNAs, suppress the level of expression of most of these mRNAs by less than two fold, and yet clearly modulate the development of cancer in mouse models. These small RNAs regulate growth and cell death genes, both modulators of tumor growth, and they also shape developmental transitions. The first Overall Aim of the Program is to Investigate the effects of loss of miRNA functions on cell viability, developmental processes and the development of malignancies. The three projects are investigating the general roles of miRNAs in gene regulation including their mechanisms of action, the consequence of loss of all miRNAs in Dicer null cell lines, and the relationship between miRNAs and differentiation of mesenchymal tumors and stem cells. Targeted mouse genetics will be used to investigate the roles of miRI43-145 cluster in development and tumor suppression. This will involve exploration of the effects of activation of this family of miRNAs in
tumors in vivo. The second Overall Aim is to Explore the roles of other types of non-coding RNAs in normal and malignant cells. The population of non-coding RNAs will be characterized in Dicer null and tumor cells in search of RNAi-related transcriptional regulation. This includes further investigation of possible Argonaute functions in the nucleus and the roles of non-coding RNAs generated from most promoters by divergent transcription. The large intervening non-coding RNAs (lincRNAs) regulated by p53. and their roles in tumor biology will be investigated using targeted mouse genetics. The third Overall Aim is to investigate the interactions of tumor suppressor genes Rb and p53 and non-coding RNAs in control of cancer and the plasticity of the differentiation state of cells. The relationship of line RNAs and p53 and of Rb and miRNAs in developmental transition and in maintaining cell state will be investigated. The interactions and involvement of Rb and miRNAs in induction of cell death following DNA damage will also be studied.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanoformulations for siRNA Delivery to Ovarian Cancer
-
批准号:7983674
-
项目类别:
-
资助金额:$26.9万
-
财政年份:2010
-
负责人:Phillip A Sharp
-
依托单位:
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
-
批准号:7913508
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2009
-
负责人:Phillip A Sharp
-
依托单位:
TREATMENT OF CANCER WITH siRNA DELVIERED BY NANOPARTICLES
-
批准号:7738123
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
-
批准号:9036337
-
项目类别:
-
资助金额:$47.86万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
-
批准号:8686767
-
项目类别:
-
资助金额:$45.39万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
-
批准号:8826043
-
项目类别:
-
资助金额:$47.74万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Stress and proliferation states impact microRNA-mediated regulation in cancer
-
批准号:7848122
-
项目类别:
-
资助金额:$49.5万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
-
批准号:8501813
-
项目类别:
-
资助金额:$45.97万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Stress and proliferation states impact microRNA-mediated regulation in cancer
-
批准号:8072151
-
项目类别:
-
资助金额:$48.02万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Stress and proliferation states impact microRNA-mediated regulation in cancer
-
批准号:8265281
-
项目类别:
-
资助金额:$48.02万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Stress and proliferation states impact microRNA-mediated regulation in cancer
-
批准号:7674684
-
项目类别:
-
资助金额:$40.97万
-
财政年份:2008
-
负责人:Phillip A Sharp
-
依托单位:
Cancer and Gene Regulation by Short RNAs
-
批准号:7225444
-
项目类别:
-
资助金额:$26.17万
-
财政年份:2006
-
负责人:Phillip A Sharp
-
依托单位:
Common Facilities and shRNA Vector Libraries
-
批准号:7225447
-
项目类别:
-
资助金额:$19.04万
-
财政年份:2006
-
负责人:Phillip A Sharp
-
依托单位:
CORE FACILITY
-
批准号:6300270
-
项目类别:
-
资助金额:$13.53万
-
财政年份:2000
-
负责人:Phillip A Sharp
-
依托单位:
TRANSCRIPTION REGULATION BY ONCOGENES
-
批准号:6300267
-
项目类别:
-
资助金额:$13.53万
-
财政年份:2000
-
负责人:Phillip A Sharp
-
依托单位:
CORE FACILITY
-
批准号:6203101
-
项目类别:
-
资助金额:$13.53万
-
财政年份:1999
-
负责人:Phillip A Sharp
-
依托单位:
TRANSCRIPTION REGULATION BY ONCOGENES
-
批准号:6203098
-
项目类别:
-
资助金额:$13.53万
-
财政年份:1999
-
负责人:Phillip A Sharp
-
依托单位:
CORE FACILITY
-
批准号:6102294
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:Phillip A Sharp
-
依托单位:
TRANSCRIPTION REGULATION BY ONCOGENES
-
批准号:6102291
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:Phillip A Sharp
-
依托单位:
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
-
批准号:9071302
-
项目类别:
-
资助金额:$144.02万
-
财政年份:1997
-
负责人:Phillip A Sharp
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: